Acute Myeloid Leukemia (AML) is a genetically and clinically heterogeneous disease that can develop at any age. While AML incidence increases with age and distinct genetic alterations are observed in younger versus older patients, current classificat...
BACKGROUND: Cardiovascular disease (CVD) remains a leading cause of preventable morbidity and mortality, highlighting the need for early risk stratification in primary prevention. Traditional Cox models assume proportional hazards and linear effects,...
BACKGROUND: Mild cognitive impairment (MCI) represents a transitional stage to Alzheimer's disease (AD), making progression prediction crucial for timely intervention. Predictive models integrating clinical, laboratory, and survival data can enhance ...
UNLABELLED: This study used explainable AI to improve the Danish FREM model for predicting one-year risk of major osteoporotic fractures in over 2.4 million individuals aged ≥ 45. A DART boosting algorithm improved performance (AUC 0.77), with explai...
PURPOSE: Pathological examination, the current gold standard for differentiating eyelid basal cell carcinoma (BCC) and sebaceous gland carcinoma (SGC), is invasive, time-consuming, and often inaccessible in primary care hospitals. Therefore, a non-in...
INTRODUCTION: Physical Activity (PA) is essential for enhancing the physical function of pre-frail and frail older adults. However, among this group, PA-levels vary significantly. Identifying the factors contributing to these differences could suppor...
OBJECTIVE: Age-related macular degeneration (AMD) is a retinal disorder that significantly impairs vision. This study investigates various machine learning models for predicting AMD risk, laying the groundwork for further research using big data and ...
Abdominal aortic aneurysm (AAA) progression carries a significant rupture risk, demanding accurate prediction models beyond traditional methods that rely on limited clinical parameters and often overlook complex factor interplay. We aimed to enhance ...
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Nov 3, 2025
This study aimed to explore the prognostic value of the artificial intelligence-assisted lesion tracking applied to prostate-specific membrane antigen (PSMA) PET in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with PS...
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Nov 3, 2025
Prostate-specific membrane antigen (PSMA) PET has the potential to monitor the response to taxane-based chemotherapy in patients with prostate cancer and shows promise for predicting outcomes and improving response evaluation. This retrospective stud...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.